Oct 31, 2025 10:22 PM
https://www.zmescience.com/medicine/amer...rates-down
EXCERPTS: America’s obesity rates have constantly been rising. Over 40% of Americans are obese, and a whopping 73.6% of U.S. adults are overweight, according to a CDC estimate. The numbers, unfortunately, keep going up. But now, there’s a blip in the data.
According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% in 2025. This adds up to 7.6 million fewer obese adults.
But there’s also a catch. It’s not that Americans are eating healthier or working out more. The difference, it seems, comes from weight loss drugs.
Ozempic wasn’t originally licensed as a weight loss treatment. It was meant as a treatment for type 2 diabetes, which can help you to manage blood sugar levels. However, the active ingredient in Ozempic, semaglutide, can help to regulate appetite.
[...] This could be a turning point for obesity in the US. But let’s call a spade a spade. This isn’t a victory for public health in the traditional sense. We haven’t suddenly found a collective passion for kale and marathons. In fact, the report throws a nasty curveball... (MORE - missing details)
EXCERPTS: America’s obesity rates have constantly been rising. Over 40% of Americans are obese, and a whopping 73.6% of U.S. adults are overweight, according to a CDC estimate. The numbers, unfortunately, keep going up. But now, there’s a blip in the data.
According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% in 2025. This adds up to 7.6 million fewer obese adults.
But there’s also a catch. It’s not that Americans are eating healthier or working out more. The difference, it seems, comes from weight loss drugs.
Ozempic wasn’t originally licensed as a weight loss treatment. It was meant as a treatment for type 2 diabetes, which can help you to manage blood sugar levels. However, the active ingredient in Ozempic, semaglutide, can help to regulate appetite.
[...] This could be a turning point for obesity in the US. But let’s call a spade a spade. This isn’t a victory for public health in the traditional sense. We haven’t suddenly found a collective passion for kale and marathons. In fact, the report throws a nasty curveball... (MORE - missing details)